Radiopharm Theranostics Limited

RADXNASDAQHealthcare● Active

$4.21

$-0.11(-2.55%)

Market Cap$5423322

P/E Ratio—

52W High$16.25

52W Low$3.62

Avg Volume157K

Open$4.35

Beta0.80

Earnings Financials Revenue

Radiopharm Theranostics Limited (RADX) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

RADX · earnings · updated Jun 9, 2026

Latest Earnings

Q1 FY2026Report Date: Feb 27, 2026

EPS Actual

-$2.25

Est. -$1.51 · -49.0%

Revenue

$0.00B

Est. $0.00B · +48.6%

Fiscal Period

Q1 FY2026

FY ends December

Report Date

Feb 27, 2026

After Market Close

▼ Miss EPS▲ Beat Revenue

RADX reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q3 FY2026	Sep 24, 2026	-$1.91	—	—	—	$0.00B	—
▼ Q1 FY2026	Feb 27, 2026	-$1.51	-$2.25	-49.0%	$0.00B	$0.00B	+48.6%
▼ Q3 FY2025	Aug 29, 2025	-$1.58	-$1.78	-12.6%	$0.00B	$0.00B	+127.5%
— Q1 FY2025	Feb 28, 2025	—	-$1.91	—	$0.00B	—	—

Q3 FY2026

Sep 24, 2026

EPS Actual

—

EPS Est.

-$1.91

EPS Surpr.

—

Revenue

—

Q1 FY2026

Feb 27, 2026Miss

EPS Actual

-$2.25

EPS Est.

-$1.51

EPS Surpr.

-49.0%

Revenue

$0.00B

Q3 FY2025

Aug 29, 2025Miss

EPS Actual

-$1.78

EPS Est.

-$1.58

EPS Surpr.

-12.6%

Revenue

$0.00B

Q1 FY2025

Feb 28, 2025

EPS Actual

-$1.91

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Analyst Estimates

EPS Estimates

Period	Low	Consensus	High	# Analysts

Revenue Estimates

Period	Low	Consensus	High	# Analysts

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
▼ Q1 FY2026	Feb 27, 2026	-49.0%	$4.98	$4.99	+0.20%
▼ Q3 FY2025	Aug 29, 2025	-12.6%	$5.70	$5.49	-3.68%
— Q1 FY2025	Feb 28, 2025	—	$5.11	$5.00	-2.15%

Q1 FY2026+0.20%

Report Date

Feb 27, 2026

EPS Beat/Miss

-49.0%

Price Before

$4.98

Price After

$4.99

Q3 FY2025-3.68%

Report Date

Aug 29, 2025

EPS Beat/Miss

-12.6%

Price Before

$5.70

Price After

$5.49

Q1 FY2025-2.15%

Report Date

Feb 28, 2025

EPS Beat/Miss

—

Price Before

$5.11

Price After

$5.00

Avg Miss Reaction-1.74%

Beat Rate0 / 3 quarters

Largest Move-3.68% (Q3 FY2025)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Radiopharm Theranostics Limited (RADX) most recently reported earnings on February 27, 2026 for Q1 FY2026, posting EPS of $-2.25 — missing the analyst consensus of $-1.51 by -49.0%. The next RADX earnings date is expected around September 1, 2026.

Each quarter, investors track RADX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. RADX revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

RADX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

RADX earnings · 5 questions

Radiopharm Theranostics Limited's next earnings report is expected around September 1, 2026. RADX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; RADX historically reports after market close (AMC).

RADX earnings datewhen is RADX earningsRADX next earnings datewhen does RADX report earningsRADX earnings calendar

▸ Source: FMP · Radiopharm Theranostics Limited SEC filings · US GAAP · Radiopharm Theranostics Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026